The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2013
Filed:
Jul. 11, 2012
Joseph A. Bilotta, Nutley, NJ (US);
Adrian Wai-hing Cheung, Glen Rock, NJ (US);
Fariborz Firooznia, Florham Park, NJ (US);
Kevin Richard Guertin, Malden, MA (US);
Stuart Hayden, Manalapan, NJ (US);
Nancy-ellen Haynes, Cranford, NJ (US);
Christine M. Lukacs-lesburg, Short Hills, NJ (US);
Nicholas Marcopulos, North Caldwell, NJ (US);
Eric Mertz, Fair Lawn, NJ (US);
Lida Qi, Killingworth, CT (US);
Yimin Qian, Wayne, NJ (US);
Sung-sau SO, Verona, NJ (US);
Jenny Tan, New Providence, NJ (US);
Kshitij C. Thakkar, Clifton, NJ (US);
Joseph A. Bilotta, Nutley, NJ (US);
Adrian Wai-Hing Cheung, Glen Rock, NJ (US);
Fariborz Firooznia, Florham Park, NJ (US);
Kevin Richard Guertin, Malden, MA (US);
Stuart Hayden, Manalapan, NJ (US);
Nancy-Ellen Haynes, Cranford, NJ (US);
Christine M. Lukacs-Lesburg, Short Hills, NJ (US);
Nicholas Marcopulos, North Caldwell, NJ (US);
Eric Mertz, Fair Lawn, NJ (US);
Lida Qi, Killingworth, CT (US);
Yimin Qian, Wayne, NJ (US);
Sung-Sau So, Verona, NJ (US);
Jenny Tan, New Providence, NJ (US);
Kshitij C. Thakkar, Clifton, NJ (US);
Hoffmann-La Roche Inc., Nutley, NJ (US);
Abstract
The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein the variables are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.